A January 2026 study (1) investigated the effectiveness of concentrated bone marrow aspirate concentrate (BMAC) injections in patients with plantar fasciitis who did not respond to conventional treatment. Patient data was analyzed in those diagnosed with chronic plantar fasciitis who received BMAC injections. Bone marrow aspirate was harvested from the iliac crest, concentrated, and injected into the area of pain points in the plantar fascia. Visual analogue scale (VAS) pain scores were documented prior to and following the BMAC injection at six, ten, 24, and 48 weeks. Results: Patients experiencing persistent plantar fasciitis who underwent BMAC injection demonstrated and maintained a statistically significant decrease in VAS pain scores during assessments at each postoperative follow-up, lasting up to 48 weeks, with no adverse effects noted at either the donor or injection sites. These findings suggest that BMAC injection may serve as a safe treatment option that offers rapid pain relief.
de Cesar Netto C, Day J, Auster H, Schon L. Outcomes of iliac crest bone marrow aspirate injection in the treatment of recalcitrant plantar fasciitis. International Orthopaedics. 2026 Jan 5:1-5.
Marc Darrow, M.D., J.D., is one of the world’s most experienced Regenerative Medicine doctors. He has more than 30 Years of expertise in regenerative medicine techniques and has treated thousands of patients. He uses non-surgical therapy to reduce pain in joints, tendons, ligaments, and a variety of other ailments and disorders throughout the body, including back and neck discomfort. He taught at UCLA and received Board Certification in Physical Medicine and Rehabilitation.
